CS Paper Radar

AutoNovo: Agentic Program Search Discovers Transferable Nucleic Acid Design Algorithms

Joel Shor, Subhashini Venugopalan

cs.LG cs.AIq-bio.QM ·submitted 2026-10-12 06:08 UTC · v1
published

Abstract

In-silico optimization of nucleic acids relies on predictive oracles that imperfectly capture biological function, so sequences optimized against one model may exploit model-specific artifacts and fail to generalize to independent models. Recent studies have shown that not all designers generalize equally well to independent models. In this work, we use agentic program search to iteratively propose, execute, evaluate, and revise code for nucleic-acid designers. We describe the successful strategies used to prompt the search. AutoNovo designers achieved the best observed mean among the evaluated methods on 3/3 DNA-design tasks in terms of in-silico performance, and 6/6 transfer tasks in terms of independent models. The designers come from a family of discovered nucleic acid designers rather than a single universal best designer. We plan to release the resulting designers. These results are the first steps in creating nucleic acid designers that maximize cross-model generalization, and thus improving the odds that in-silico designed sequences reflect real biology.

Comment
40th Conference on Neural Information Processing Systems (NeurIPS 2026). Workshop: Agentic AI for Biological Discovery

Closest papers

Nearest neighbours by meaning across the whole index.

From DNA Design to DNA Slimming: Auditable Agentic Discovery of a Deletion-Only Designer

cs.LG cs.NEq-bio.GN ·2026-09-30 ·Joel Shor
publishedbenchmark similarity 0.70
Abstract · 40th Conference on Neural Information Processing Systems (NeurIPS 2026). Workshop: Agentic AI for Biological Discovery

Compact regulatory DNA can free up space in vector payloads, reduce synthesis and assay burden, and expose which sequence features drive predicted activity. Yet most model-based nucleic-acid designers optimize fixed-length sequences through substitutions; they do not ask which bases of an existing functional element can be removed while retaining predicted activity. We define the task of sequence slimming as selecting an exact-length, order-preserving subsequence while retaining activity. Modeled on the design benchmark NucleoBench, we propose a quantitative evaluation for slimming that balances sequence reduction with maintaining function. Each slimmer must return both the subsequence and its source indices, which can be used to verify that the slimmer obeyed task requirements. To our knowledge, this is the first dedicated benchmark of this deletion-only problem. The coding agent Empirical Research Assistant (ERA) then searched over executable designer programs. ERA received the task prompt and a successful substitution-only designer GrAdaBeam as a starting program, and it modified the designer to produce GRADASLIM. We report held-out evaluations for five transcription-factor binding targets, comparing random, greedy, and ERA-guided slimming at 400 and 100 bp. ERA has the highest mean in 9/10 settings. Paired bootstrap intervals for ERA minus greedy are above zero in all five 400-bp settings, below zero in one 100-bp setting, and overlap zero in the remaining four.

0.33

MoLRSI: A Recursive Self-Improving AI agent for Molecular Discovery

cs.AI ·2026-10-29 ·Yikun Zhang, Xiwei Cheng, Mingze Yuan, Yu Zhang, Brian Shim +13 more
community pick similarity 0.66
Abstract · v2: updated the author list

Molecular discovery requires navigating vast combinatorial search spaces while balancing competing biological objectives. AI agents can automate expert-defined molecular design protocols, but automation alone does not address how to optimize workflows for new tasks or improve their development through experience. Here we introduce MoLRSI, an AI agent that combines systematic optimization of workflows and model architectures with persistent cross-task memory to recursively improve its search policy for molecular discovery. Workflow performance, refinement outcomes, and execution feedback guide subsequent searches, allowing the agent to improve both its workflows and its strategy for developing them. We evaluate MoLRSI in two challenging molecular discovery settings that require balancing competing properties. In antibiotic discovery, MoLRSI developed a screening workflow balancing antibacterial activity, cytotoxicity and structural novelty, achieving an experimental hit rate of 15.9%, compared with 8.7% for a previous expert-led workflow using the same training data and screening library. In de novo peptide-MHC binder design, MoLRSI developed workflows that jointly consider target binding and specificity, producing eight experimentally validated hits against MART-1 and SARS-CoV-1 pMHCs with preferential binding over tested off-targets while Claude Science completely failed. These findings demonstrate how experience-guided workflow optimization can address competing discovery objectives while improving the search strategies used in subsequent campaigns.

0.39

Can agents reliably design therapeutic antibodies?

cs.LG q-bio.QM ·2026-10-31 ·Asli Alpman, Nick Bhattacharya, Aaron Solomon, Hunter Elliott
similarity 0.66
Abstract

Recent work has demonstrated agents driving protein design workflows, either through orchestration of specialized tools or direct manipulation of sequences. Yet the fidelity with which agents follow protein design instructions and the factors contributing to their effectiveness remain understudied. We examine agentic antibody design under two settings: when explicit molecular-editing instructions are provided and when agents receive only previously-scored sequences and are prompted to propose improvements. We call the first task-guided and the second black-box design. For the task-guided setting, we curate ten expert-validated affinity-improvement tasks and show that LLM judges closely reproduce programmatic evaluations of instruction following. We then study two augmentations: access to antibody-relevant tools and to previously scored design history. Tools improve instruction following (IF) and sequence space exploration while reducing optimization performance, whereas design history reduces IF but improves optimization performance at the expense of exploration. Finally, we combine taskguided and black-box design within an in silico optimization loop and show that our agentic optimizer performs comparably to an established Bayesian optimization baseline.

0.08

Navigating Route Latent Space for Synthesizable Molecular Design

cs.AI cs.CE ·2026-10-06 ·Tao Li, Tuan Vinh, Monika Raj, Yuan Fang, Zhichun Guo +1 more
position similarity 0.65
Abstract

Goal-directed molecular design has advanced rapidly, yet a substantial proportion of designed molecules remain difficult to synthesize in practice, limiting their real-world utility. Prior synthesizability-aware methods either project generated molecules back to synthesizable analogs that deviate from the intended target, or optimize directly in discrete synthesis spaces that lack a continuous landscape for efficient search. We argue that this limitation mainly comes from the search space rather than the optimizer. To address this, we propose RouteFlow, a framework that reformulates synthesizable molecular design as a search over a continuous route latent space, where each latent maps back to a complete synthesis route and synthesizability is inherently preserved. To navigate this space, we adopt reward-guided flow matching as an efficient sampler that steers toward high-property regions. Since reward optimization may push latents off the manifold of real synthesis routes, where decoding becomes unreliable, we further introduce a cycle-consistency mechanism to stabilize fine-tuning. Across 16 optimization tasks from Therapeutic Data Commons, RouteFlow achieves the best sample efficiency among synthesizability-aware baselines, with the best synthetic accessibility and the highest retrosynthesis success rate. Our results also confirm that the proposed cycle-consistency reliably keeps optimization on-manifold while improving target properties, supporting effective synthesizable molecular discovery.

0.17

Agentic BAIM-LLM Evaluation (ABLE): Benchmarking LLM Use of Protein Design Tools

cs.AI cs.CYq-bio.QM ·2026-09-05 ·Bryce Cai, Geetha Jeyapragasan, Samira Nedungadi, Jake Yukich, Seth Donoughe
publishedbenchmarkhighly cited similarity 0.64
Abstract · Last revised in February 2026; presented without further revision. An earlier revision at was presented at the NeurIPS 2025 Workshop on Bios…

We introduce ABLE, a benchmark for evaluating LLM agents' ability to use biological AI models (BAIMs), such as ProteinMPNN and AlphaFold3, in dual-use protein design workflows. ABLE assesses agent performance through a set of tasks spanning structure retrieval, sequence generation, and design validation. We evaluate 15 frontier models and find that seven refuse all tasks, while the remaining models exhibit substantial performance differences. Claude Sonnet 4 and Gemini 3 Pro achieve the highest scores across information retrieval, tool selection, and tool use. We further compare model performance on a subset of tasks against an expert human baseline. Our results suggest that current LLMs can substantially lower barriers to protein design, but remain inconsistent in planning, strategy generation, and integrating biological knowledge with tool use.

0.57

GenomeHarness: Harnessing Al Agents for Reliable Adaptation of Genome Language Models

cs.CE ·2026-08-22 ·Weicai Long, Yusen Hou, Houcheng Su, Junning Feng, Yanlin Zhang
benchmark similarity 0.64
Abstract · 10 pages, 4 figures

Pretrained genome language models provide reusable representations for DNA sequence analysis, but turning them into reliable downstream predictors remains non-trivial. Their practical performance depends strongly on fine-tuning recipes, and default recipes reported in prior studies may be suboptimal for new tasks or model backbones, making weak downstream results difficult to interpret. These requirements place a substantial operational burden on many intended users, whose expertise is often centered on biological questions and interpretation rather than machine-learning engineering. Reliable use of genome language models therefore requires more than conventional AutoML-style tuning: it requires a systematic, budget-aware, and auditable procedure that lowers the barrier to downstream adaptation. We present GenomeHarness, an agentic harness for adapting genome language models through controlled search over fine-tuning recipes. GenomeHarness combines an AI agent for proposing and repairing recipe edits, a harness for protocol-constrained execution, resource management, and test isolation, and a Monte Carlo tree search controller for allocating search effort across recipe lineages. We evaluate GenomeHarness on DNABERT2 and NTv2-100M-Multi across the NT Benchmark and Genomic Benchmarks. Final evaluation is performed using three random seeds after recipe freezing. Across 52 model-task settings, GenomeHarness improves mean test MCC in 47 settings, including 24 of 26 DNABERT2 settings and 23 of 26 NTv2-100M-Multi settings. The gains are especially pronounced on Genomic Benchmarks and on tasks where the root recipe is unstable or poorly matched, such as human ocr ensembl task. Search traces further show that GenomeHarness progressively identifies stronger recipes, turning downstream adaptation into a controlled and auditable workflow rather than a manual tuning process.

0.22

AgentFold: Closed-Loop Agentic Search for Protein Folding Model Design

cs.AI ·2026-08-27 ·Mingquan Liu, Jiangyu Chen, Hanqun Cao, Xujun Zhang, Pengsen Ma +7 more
top venuecode/data similarity 0.63
Abstract

Scientific LLM agents have shown promise in literature reasoning, tool use, and experiment planning, but it remains unclear whether they can autonomously improve large, tightly coupled scientific machine-learning systems through executable code changes and computationally expensive validation. We study this question in protein folding, where progress requires coordinated architectural modifications, multi-objective evaluation, and domain-aware interpretation. We present AgentFold, a multi-agent framework that formulates folding-model development as a closed-loop search over executable code variants. Starting from ESMFold, AgentFold proposes hypotheses, implements and debugs code-level modifications, evaluates model variants, analyzes experimental outcomes, and stores both successful and failed interventions in structured memory. An MCTS-style policy allocates computational resources across high-scoring search branches. On an engineering-scale protein-folding codebase comprising more than 2,000 lines of code, AgentFold explores approximately 80 model variants using approximately 5,000 GPU-hours and 170 million LLM tokens. Under a matched computational budget, AgentFold improves the best lDDT by 7.5% over independent Codex proposals and outperforms a random-search control. Beyond model improvement, the resulting intervention traces reveal recurring empirical design patterns: stable gains tend to arise from early, soft, learnable priors and gated refinement, whereas direct geometric perturbations and geometry-conditioned feedback often destabilize training. The code and experimental resources are publicly available at https://github.com/lmqfly/AgentFold.

0.51

Aptamers as a sandbox for lab-in-the-loop agentic molecular discovery

cs.AI q-bio.BMq-bio.QM ·2026-10-17 ·Zachary Cutts, John Coller, Rachel Chen, Hua Tang, Mathias Bellaiche +7 more
hot direction similarity 0.62
Abstract · Equal leadership (co-senior authors): Pooja Rao and Annalisa Pawlosky. 34 pages, 4 main figures, 1 main table, 3 supplementary figures, 4 su…

Despite breakthroughs in AI-driven molecular generation, existing discovery pipelines operate largely in silico, with wet-lab feedback reserved for validation rather than iterative improvement. Whether large language model (LLM)-based reasoning agents can accelerate de novo discovery by iterating with lab data remains unproven. Here we use protein-binding aptamer design as a sandbox (1-2 week cycles, \$1-\$3 per candidate) to demonstrate a wet lab in a closed loop with AI systems. We tasked agentic pipelines with developing aptamer binders against $α$-thrombin and myoglobin across three design-test-improve cycles ($\sim$1,000 candidates per round; $\sim$4,400 constructs). Statistically significant, bead-corrected on-target hit rates among new candidates rose across rounds from 0.0% in Round 1 to 26.0% in Round 2 and 42.1% in Round 3 on $α$-thrombin (37.1% excluding literature motif descendants), and from 10.2% in Round 1 to 3.7% in Round 2 and 33.5% in Round 3 on myoglobin. Single-clone bead-binding titrations of eight full-length $α$-thrombin candidates confirmed concordance with pooled sequencing enrichment (Pearson $r = 0.90$). In these assays, literature-derived motifs engineered by the agents to reduce off-target reactivity in the pooled screen reached apparent affinities of $K_D = 24.6$--$133$ nM, whereas de novo scaffolds showed low-micromolar binding ($K_D > 1\ μ$M). We also report how our pipelines used myoglobin binding data to exploit the G-quadruplex binder space, diagnose cross-reactivity as on-target specificity dropped from 75.0% to 19.1%, and recover by developing strategies that restored specificity to 72.4%. We demonstrate that empirical lab data is more valuable than existing computational proxies, showing how iterative experimental feedback enables AI agents to diagnose assay artifacts and refine molecular designs across rounds.

0.52